Loading
Acarix AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 22 Sept 2025.
Acarix AB: what insiders have been doing
Every trade that managers of Acarix AB disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. Acarix AB has had no insider filing for more than a year; the last one goes back to 22 September 2025.
Our records for Acarix AB go back to 2021, with 5 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Insider Decl.
6
Thresholds
n/a
Buy Volume
€72,006
5 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAamir Mahmood3 buys
Jan Poulsen1 buy
Since the insiders bought
- -38.2%Entry SEK 0.30 · Close 16 Oct 2026 SEK 0.19
- -29.1%Entry SEK 0.31 · Close at T+365 SEK 0.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 19,431 of 24,148 companies
30.6
score / 100
Value13
Quality48
FCF yld-13%
Earn yld-17%
EV/EBITDA·
ROE-86%
Gross mgn85%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.25
Analyst consensus
1 analystsSEK 0.40Target SEK 0.40(+63%)SEK 0.40
Income statement
RevenueSEK 7.4M
Gross profitSEK 6.2M85% margin
EBITDA-SEK 44.6M-606% margin
Net income-SEK 48.1M-653.3% margin
Valuation
P/Book6.8x
Beta-0.22
Balance sheet & cash
Market capSEK 290.9M
Free Cash Flow-SEK 38M
Profitability & ownership
ROE-86.1%
ROA-48.3%
% insiders12.0%
% institutions8.3%
Last declaration on 22 September 2025
Declarations6 total
150,000 shares@ SEK 0.29770.016% mcap100.0% of flowAktieISIN SE0009268717FI:A003S480-1
Canonical exit: 16 Dec 2025 (T+90)
385,553 shares@ SEK 0.290.039% mcap14.9% of flowAktieISIN SE0009268717FI:A003S110-1
Canonical exit: 4 Dec 2025 (T+90)
1,382,000 shares@ SEK 0.230.11% mcap41.4% of flowAktieISIN SE0009268717FI:A003L497-2
Canonical exit: 14 May 2025 (T+90)
751,549 shares@ SEK 0.220.058% mcap22.3% of flowAktieISIN SE0009268717FI:A003M644-2
Canonical exit: 10 Jun 2025 (T+90)
588,753 shares@ SEK 0.280.056% mcap21.4% of flowAktieISIN SE0009268717FI:A003H027-2
Canonical exit: 27 Nov 2024 (T+90)
150,000 shares@ SEK 0.40100.0% of flowTeckningsoptionISIN SE0009268717FI:A001P458-1
6 of 6 declarations
About Acarix AB
Acarix AB is a company focused on developing diagnostic solutions for cardiovascular diseases. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
